1-12 of 12
prescribing behavior
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study

Huan Wang, Ruth L.M. Cordiner, Yu Huang, Louise Donnelly, Simona Hapca, Andrew Collier, John McKnight, Brian Kennon, Fraser Gibb, Paul McKeigue, Sarah H. Wild, Helen Colhoun, John Chalmers, John Petrie, Naveed Sattar, Thomas MacDonald, Rory J. McCrimmon, Daniel R. Morales, Ewan R. Pearson, Scottish Diabetes Research Network Epidemiology Group, Luke Blackbourn, Scott Cunningham, Fraser Gibb, Graham Leese, Robert Lindsay, David McAllister, Stuart McGurnaghan, Sam Philip
Journal: Diabetes Care
Diabetes Care 2023;46(5):967–977
https://doi.org/10.2337/dc22-1238
Published: 21 March 2023
View article titled, Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study
Open the PDF for Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study in another window
Journal Articles

Erratum. Targeting Technology in Underserved Adults With Type 1 Diabetes: Effect of Diabetes Practice Transformations on Improving Equity in CGM Prescribing Behaviors. Diabetes Care 2022;45:2231–2237

Priyanka Mathias, Lakshmi Priyanka Mahali, Shivani Agarwal
Journal: Diabetes Care
Diabetes Care 2023;46(1):222
https://doi.org/10.2337/dc23-er01
Published: 11 November 2022
View article titled, Erratum. Targeting Technology in Underserved Adults With Type 1 Diabetes: Effect of Diabetes Practice Transformations on Improving Equity in CGM Prescribing Behaviors. Diabetes Care 2022;45:2231–2237
Open the PDF for Erratum. Targeting Technology in Underserved Adults With Type 1 Diabetes: Effect of Diabetes Practice Transformations on Improving Equity in CGM Prescribing Behaviors. Diabetes Care 2022;45:2231–2237 in another window
Journal Articles

Using Data to Improve the Management of Diabetes: The Tayside Experience

Moneeza K. Siddiqui, Christopher Hall, Scott G. Cunningham, Rory McCrimmon, Andrew Morris, Graham P. Leese, Ewan R. Pearson
Journal: Diabetes Care
Diabetes Care 2022;45(12):2828–2837
https://doi.org/10.2337/dci22-0003
Published: 26 October 2022
View article titled, Using Data to Improve the Management of Diabetes: The Tayside Experience
Open the PDF for Using Data to Improve the Management of Diabetes: The Tayside Experience in another window
Journal Articles

Targeting Technology in Underserved Adults With Type 1 Diabetes: Effect of Diabetes Practice Transformations on Improving Equity in CGM Prescribing Behaviors

Priyanka Mathias, Lakshmi Priyanka Mahali, Shivani Agarwal
Journal: Diabetes Care
Diabetes Care 2022;45(10):2231–2237
https://doi.org/10.2337/dc22-0555
Published: 19 September 2022
View article titled, Targeting Technology in Underserved Adults With Type 1 Diabetes: Effect of Diabetes Practice Transformations on Improving Equity in CGM Prescribing Behaviors
Open the PDF for Targeting Technology in Underserved Adults With Type 1 Diabetes: Effect of Diabetes Practice Transformations on Improving Equity in CGM Prescribing Behaviors in another window
Journal Articles

Prescribing Paradigm Shift? Damned If You Do, Damned If You Don’t

Nikolaus Marx, Peter J. Grant
Journal: Diabetes Care
Diabetes Care 2020;43(9):1991–1993
https://doi.org/10.2337/dci20-0027
Published: 11 August 2020
View article titled, Prescribing Paradigm Shift? Damned If You Do, Damned If You Don’t
Open the PDF for Prescribing Paradigm Shift? Damned If You Do, Damned If You Don’t in another window
Journal Articles

Prescribing by Ethnicity: (Im)precision Medicine?

Nishi Chaturvedi, Sophie Eastwood
Journal: Diabetes Care
Diabetes Care 2020;43(8):1687–1689
https://doi.org/10.2337/dci20-0015
Published: 10 July 2020
View article titled, Prescribing by Ethnicity: (Im)precision Medicine?
Open the PDF for Prescribing by Ethnicity: (Im)precision Medicine? in another window
Journal Articles

Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology–Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium–Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists as First-Line Monotherapy (or Add-on to Metformin Monotherapy) in Type 2 Diabetes in Scotland

Thomas M. Caparrotta, Luke A.K. Blackbourn, Stuart J. McGurnaghan, John Chalmers, Robert Lindsay, Rory McCrimmon, John McKnight, Sarah Wild, John R. Petrie, Sam Philip, Paul M. McKeigue, David J. Webb, Naveed Sattar, Helen M. Colhoun
Journal: Diabetes Care
Diabetes Care 2020;43(9):2034–2041
https://doi.org/10.2337/dc20-0120
Published: 24 June 2020
View article titled, Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology–Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium–Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists as First-Line Monotherapy (or Add-on to Metformin Monotherapy) in Type 2 Diabetes in Scotland
Open the PDF for Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology–Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium–Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists as First-Line Monotherapy (or Add-on to Metformin Monotherapy) in Type 2 Diabetes in Scotland in another window
Journal Articles

Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013–2018

Chintan V. Dave, Sebastian Schneeweiss, Deborah J. Wexler, Gregory Brill, Elisabetta Patorno
Journal: Diabetes Care
Diabetes Care 2020;43(4):921–924
https://doi.org/10.2337/dc19-1943
Published: 10 February 2020
View article titled, Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013–2018
Open the PDF for Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013–2018 in another window
Includes: Supplementary data
Journal Articles

Response to Comment on Russell-Jones et al. Diabetes Care 2017;40:943–950. Comment on Bowering et al. Diabetes Care 2017;40:951–957

Bruce W. Bode, Keith Bowering, David Russell-Jones
Journal: Diabetes Care
Diabetes Care 2018;41(3):e29–e30
https://doi.org/10.2337/dci17-0051
Published: 12 February 2018
View article titled, Response to Comment on Russell-Jones et al. Diabetes Care 2017;40:943–950. Comment on Bowering et al. Diabetes Care 2017;40:951–957
Open the PDF for Response to Comment on Russell-Jones et al. Diabetes Care 2017;40:943–950. Comment on Bowering et al. Diabetes Care 2017;40:951–957 in another window
Journal Articles

Prescribing Quality and Prediction of Clinical Outcomes in Patients With Type 2 Diabetes: A Prospective Cohort Study

Kirsten P.J. Smits, Grigory Sidorenkov, Gerjan Navis, Margriet Bouma, Marianne A. Meulepas, Henk J.G. Bilo, Petra Denig
Journal: Diabetes Care
Diabetes Care 2017;40(7):e83–e84
https://doi.org/10.2337/dc17-0236
Published: 04 May 2017
View article titled, Prescribing Quality and Prediction of Clinical Outcomes in Patients With Type 2 Diabetes: A Prospective Cohort Study
Open the PDF for Prescribing Quality and Prediction of Clinical Outcomes in Patients With Type 2 Diabetes: A Prospective Cohort Study in another window
Journal Articles

Recent Antihyperglycemic Prescribing Trends for U.S. Privately Insured Patients With Type 2 Diabetes

Fredric J. Cohen, MD, Cheryl A. Neslusan, PHD, Jonathan E. Conklin, Xue Song, PHD
Journal: Diabetes Care
Diabetes Care 2003;26(6):1847–1851
https://doi.org/10.2337/diacare.26.6.1847
Published: 01 June 2003
View article titled, Recent Antihyperglycemic Prescribing Trends for U.S. Privately Insured Patients With Type 2 Diabetes
Open the PDF for Recent Antihyperglycemic Prescribing Trends for U.S. Privately Insured Patients With Type 2 Diabetes in another window
Meeting Abstracts

Impact of type 1 and type 2 diabetes on patterns and costs of drug prescribing: a population-based study.

J M Evans, T M MacDonald, G P Leese, D A Ruta, A D Morris
Journal: Diabetes Care
Diabetes Care 2000;23(6):770–774
https://doi.org/10.2337/diacare.23.6.770
Published: 01 June 2000
View article titled, Impact of type 1 and type 2 diabetes on patterns and costs of drug prescribing: a population-based study.
Open the PDF for Impact of type 1 and type 2 diabetes on patterns and costs of drug prescribing: a population-based study. in another window